Bullish
Hologic to Present New Data at ASCO 2026 Demonstrating the Clinical Impact of the Breast Cancer Index® Test on Extended Endocrine Therapy Decisions
Hologic, Inc. announced new data on how its Breast Cancer Index® (BCI™) Test influences decisions for extended endocrine therapy in early-stage, hormo...